These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7612732)

  • 1. Serum advanced glycosylation end-products in patients on hemodialysis and CAPD.
    Ateshkadi A; Johnson CA; Founds HW; Zimmerman SW
    Perit Dial Int; 1995; 15(2):129-33. PubMed ID: 7612732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on continuous ambulatory peritoneal dialysis.
    Yu CC; Wu MS; Wu CH; Yang CW; Huang JY; Hong JJ; Fan Chiang CY; Leu ML; Huang CC
    Perit Dial Int; 1997; 17(3):262-8. PubMed ID: 9237287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD.
    Papanastasiou P; Grass L; Rodela H; Patrikarea A; Oreopoulos D; Diamandis EP
    Kidney Int; 1994 Jul; 46(1):216-22. PubMed ID: 7933840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-dialysis glycemic control is an independent predictor of mortality in type II diabetic patients on continuous ambulatory peritoneal dialysis.
    Wu MS; Yu CC; Wu CH; Haung JY; Leu ML; Huang CC
    Perit Dial Int; 1999; 19 Suppl 2():S179-83. PubMed ID: 10406515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemoglobin A1c in patients under periodic hemodialysis or continuous ambulatory peritoneal dialysis].
    Blumberg A; Marti HR
    Schweiz Med Wochenschr; 1986 Feb; 116(7):208-11. PubMed ID: 3952477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated hemoglobin measured by affinity chromatography in diabetic and nondiabetic patients on long-term dialysis therapy.
    Tzamaloukas AH; Hsi KC; Quintana BJ; Merlin TL; Avasthi PS
    West J Med; 1989 Apr; 150(4):415-9. PubMed ID: 2735046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood glucose and cholesterol control improved by continuous ambulatory peritoneal dialysis in patients with end-stage renal disease and diabetes mellitus.
    Wikdahl AM; Granbom L; Sörensen JG; Stegmayr BG
    Perit Dial Int; 1993; 13 Suppl 2():S239-41. PubMed ID: 8399577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
    Madden MA; Zimmerman SW; Simpson DP
    Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis.
    Freedman BI; Shenoy RN; Planer JA; Clay KD; Shihabi ZK; Burkart JM; Cardona CY; Andries L; Peacock TP; Sabio H; Byers JR; Russell GB; Bleyer AJ
    Perit Dial Int; 2010; 30(1):72-9. PubMed ID: 20056983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemia in diabetics on dialysis with poor glycemic control: hemodialysis versus continuous ambulatory peritoneal dialysis.
    Tzamaloukas AH; Murata GH; Eisenberg B; Murphy G; Avasthi PS
    Int J Artif Organs; 1992 Jul; 15(7):390-2. PubMed ID: 1516987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical characteristics of type 2 diabetic patients on continuous ambulatory peritoneal dialysis: relationships with insulin requirement.
    Wong TY; Chan JC; Szeto CC; Leung CB; Li PK
    Am J Kidney Dis; 1999 Sep; 34(3):514-20. PubMed ID: 10469863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructosamine levels in CAPD: its value as glycemic index.
    Coronel F; Macia M; Cidoncha A; Sanchez A; Tornero F; Barrientos A; Valor R
    Adv Perit Dial; 1991; 7():253-6. PubMed ID: 1680438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative cardiac effects of hemodialysis and continuous ambulatory peritoneal dialysis.
    Alpert MA; Van Stone J; Twardowski ZJ; Ruder MA; Whiting RB; Kelly DL; Madsen BR
    Clin Cardiol; 1986 Feb; 9(2):52-60. PubMed ID: 3948441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
    Serlie MJ; Struijk DG; de Blok K; Krediet RT
    Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
    Ushigome E; Matsusaki S; Watanabe N; Hashimoto T; Nakamura N; Fukui M
    J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.